SlideShare una empresa de Scribd logo
1 de 51
Mary K. Campbell
       Shawn O. Farrell
       http://academic.cengage.com/chemistry/campbell




           Chapter 14
Viruses, Cancer, and Immunology




    Paul D. Adams • University of Arkansas
Viruses
•   Viruses are pathogens of bacteria, plants, and animals
•   Can be deadly (e.g., Ebola, HIV)
•   Can be merely annoying (e.g., Rhinovirus)
•   Viruses are small particles composed of nucleic acid and
    protein
•   Entire particle is known as a virion
•   Capsid- surround the center of the virion
•   Nucleocapsid- combination of the nucleic acid and the
    capsid
•   Membrane envelope- surrounds the nucleocapsid
•   Protein spikes- help viruses attach themselves to the host
    cell
Architecture of a Virus
Families of Viruses
The Virus Life Cycle
How Does a Virus Infect a Cell
• A Virus must attach to the
  host cell before it can
  penetrate

• A common method of
  attachment involves the
  binding of one of the spike
  proteins on envelope of the
  virus to a specific receptor
  on the host cell

• An example is HIV
  attachment
Retroviruses
• A retrovirus implies that replication is backward
  compared to the central dogma of molecular biology

• The genome of a retrovirus is single-stranded RNA

• Once it infects the cell, the RNA strand is used as
  template to make double-stranded DNA

• Retroviruses have been linked to cancer and AIDS
Life cycle of a Retrovirus
Retroviruses (Cont’d)
• Retroviruses have certain genes in common
• Coat proteins- genes for proteins of the
  nucleoplasmid
• All retroviruses have genes for reverse
  transcriptase (RT), and for envelope proteins (EP)
HIV retrovirus
- TMV, a virus of tobacco plants, is a filamentous RNA virus. Top right:
  some of the capsid proteins (cyan) have been stripped away to reveal
  the RNA helix (yellow).
- The capsid normally consists of 2130 coat protein molecules (with 16.3
  units per turn of the helix) and is about 300 nm long by 18 nm in
  diameter
- The genome is ss(+)RNA, that is a single-strand of positive-sense RNA,
HIV Genome
http://www.hiv.lanl.gov/content/sequence/HIV/MAP/landmark.html




 The HIV-1 genome contains a
 single promoter and uses
 multiple reading frames and
 alternative splicing to encode
 15 proteins from a single pre-
 mRNA species.
Summary of Retroviruses
• Retroviruses have a genome based on DNA. When
   they infect cells, their RNA is turned into DNA by RT.
   The DNA is then incorporated into the host’s DNA
   genome as a part of the replication cycle for the virus
• Retroviruses all have certain genes in common
• Some retroviruses also have identifiably unique
   genes, e.g., the Sarcoma oncogene and the Rous
   sarcoma virus
- Viruses are also used in Gene Therapy (see
   Biochemical Connections, pg. 412)
US HIV baby 'cured' by early drug treatment
News headline - Mar 4 2013
•   A baby girl in the US born with HIV appears to have been cured after very early treatment
    with standard drug therapy, doctors say.
•   The Mississippi child is now two-and-a-half years old and has been off medication for about a
    year with no signs of infection.
•   More testing needs to be done to see if the treatment - given within hours of birth - would
    work for others.
•   If the girl stays healthy, it would be the world's second reported 'cure'.
•   Dr Deborah Persaud, a virologist at Johns Hopkins University in Baltimore, presented the
    findings at the Conference on Retroviruses and Opportunistic Infections in Atlanta.
•   "This is a proof of concept that HIV can be potentially curable in infants," she said.
•   Cocktail of drugs In 2007, Timothy Ray Brown became the first person in the world believed
    to have recovered from HIV.
•   His infection was eradicated through an elaborate treatment for leukaemia that involved the
    destruction of his immune system and a stem cell transplant from a donor with a rare genetic
    mutation that resists HIV infection.
•   In contrast, the case of the Mississippi baby involved a cocktail of widely available drugs,
    known as antiretroviral therapy, already used to treat HIV infection in infants.
•   It suggests the swift treatment wiped out HIV before it could form hideouts in the body.
•   These so-called reservoirs of dormant cells usually rapidly reinfect anyone who stops
    medication, said Dr Persaud.
Death toll from new SARS-like virus climbs to NINE
– March 12 2013
 •   http://edition.cnn.com/2013/03/13/health/new-coronavirus-case/index.html?eref=mrss_igoogle_cnn
 •   March 13 2013, (CNN) -- There has been another confirmed case of a mysterious new
     SARS-like virus.
 •   The Saudi health ministry informed the World Health Organization that a 39-year-old man
     was hospitalized with the novel coronavirus on February 28 and died two days later.
 •   So far, WHO has recorded 15 confirmed cases of the novel coronavirus, including nine
     deaths, since the fall.
 •   The spread of coronavirus in UK
 •   The Saudi patient did not appear to have had any contact with anyone who was already
     infected. As a result, WHO is investigating other potential exposure sources.
Viruses – Biochemical connections
• Read Gene Therapy Page 412-413
• Adenosine deaminase
• Severe combined immune deficiency (SCID)
Immunology
The Immune System
• The immune system allows for the distinction between self
  from nonself

• This allows cells and molecules responsible for immunity to
  recognize and destroy pathogens

• The immune system can also go awry in distinguishing self
  from nonself. This results in an autoimmune disease, in
  which the immune system attacks the body’s own tissues

• Allergies are also another type of improper functioning of the
  immune system

• Can be cellular, molecular, acquired or innate (always
  present)
Innate Immunity
• There are several parts to innate immunity: physical
  barriers(skin, mucus), cells of the immune system
  (dendritic cells, macrophage, and natural killer
  (NK) cells)
  • Dendritic cells are members of a class of cells called
    antigen-presenting cells (APCs) (1st line of
    defense)
  • T cells release chemicals called cytokines that
    stimulate other members of the immune system, e.g.
    killer T cells and B cells (a level of control)
  • Another important cell type in the innate immunity
    system is the natural killer (NK) cells, which is a type
    of leukocyte.
Dendritic cells
NK Cells
Innate Immunity (T-cells)
• T cells or T lymphocytes belong to a group of white
  blood cells known as lymphocytes,
• play a central role in cell-mediated immunity.
• They can be distinguished from other lymphocytes,
  such as B cells and natural killer cells (NK cells), by
  the presence of a T-cell receptor (TCR) on the cell
  surface.
• TCR binds ANTIGEN
• They are called T cells because they mature in the
  thymus.
T Cells cont
• There are several subsets of T cells, each with a
  distinct function.
• T cells differentiate, and become specialized for one
  of several possible functions
• Proliferation of killer T cells is triggered when
  macrophages bound to T cells produce small
  proteins called interleukins
Types of T Cells
Helper
•(TH cells) assist other white blood cells in immunologic processes, including
maturation of B cells into plasma cells and memory B cells, and activation of
cytotoxic T cells and macrophages.
•become activated when they are presented with peptide antigens by MHC
class II molecules, which are expressed on the surface of antigen presenting
cells (APCs).
•Once activated, they divide rapidly and secrete small proteins called
cytokines that regulate or assist in the active immune response.

Cytotoxic – Killer (CD8 cell)
•(TC cells,) destroy virally infected cells and tumor cells, and are also
implicated in transplant rejection.
•These cells recognize their targets by binding to antigen associated with
MHC class I, which is present on the surface of all nucleated cells.
T-cell
Growth and Differentiation of T cells
Interaction Between Cytotoxic T cells and
Antigen-Presenting Cells
                                  Killer T also called
                                  a CD8 cells as it is
                                  such a
                                  distinguishing
                                  feature

                                  antigen


                                  TCR
Clonal Selection
• The process by
  which only the cells
  that respond to a
  given antigen grow in
  preference to other T
  cells is called clonal
  selection

• Double recognition
  needed = control,
  activating the
  immune system is a
  serious game so you
  have to be sure!
Interaction Between Helper T Cells and
Antigen-Presenting Cells
How Helper T Cells Aid in the Development
of B Cells
Antibodies
• Antibodies are Y-shaped
  molecules consisting of
  two identical heavy
  chains and two identical
  light chains held together
  by disulfide bonds

• Antibodies are
  glycoproteins
Antibodies (Cont’d)
• The variable region is
  found at the prongs of
  the Y and is the part of
  the antibody that binds to
  the antigen

• The binding sites for the
  antibody on the antigen
  are called epitopes
Antibody Heavy and Light Chains
Monoclonal Abs
Antibodies (Cont’d)
• If a cell’s receptors encountered self-antigens that
  are recognized with high affinity, it undergoes a
  process called negative selection and is
  programmed for apoptosis, or cell death

• There are several safeguards that leads to the
  delicate balance that must be maintained by the
  immune system
Differentiation of T Cells

                             This section is a
                             huge topic (as all of
                             these sections in
                             this chapter.)

                             However this
                             Selection process is
                             covered very poorly
                             so we wont
                             emphasize it.
Summary
• Vertebrates have an immune system
• Innate immunity consists of physical barriers and
  cellular warriors
• Acquired immunity is based on two types of T cells
  and on B cells. These cells are generated randomly
  with receptors that can be specific for an
  unimaginable number of antigens
• When cells encounter their specific antigens, they
  are stimulated to multiply
Summary (cont’d)
• When cells encounter their specific antigens, they
  are stimulated to multiply
• Acquired immune cells also leave behind memory
  cells so that if the same pathogen is seen again, the
  body is faster to eliminate it
• Immune cells must be able to recognize self from
  nonself. T cells and B cells are conditioned not to
  recognize proteins from that individual
• In some cases, the immune system breaks down,
  and a person may be attacked by his or her own
  immune system leading to an autoimmune disease
Cancer
• Cancer is the leading cause of death in human
  beings

• It is characterized by cells that grow and divide out of
  control, often spreading to other tissues and causing
  them to become cancerous
Cancer (Cont’d)
•   All life-threatening cancers have at least six characteristics in
    common
    1) Cancer cells continue to grow and divide in situations in which
       normal cells do not
    2) Cancer cells continue to grow even when the neighboring cells
       send out “stop-growth” signals
    3) Cancer cell manage to keep going and avoid a “self-destruct”
       signal that usually occurs when DNA damage has occurred
    4) The can co-opt the body’s vascular system, causing the growth
       of new blood vessels to supply the cancerous cells with
       nutrients
    5) They are essentially immortal (cell culture in the lab)
    6) Cancer cells have the ability to break loose, travel to other
       parts of the body and create new which tumors make them
       lethal, this is called metastasis
What Causes Cancer?
• Changes in DNA cause changes to specific proteins
  that are responsible for controlling the cell cycle

• Most mutations of DNA affect two types of genes:
  1) Tumor suppressor, a gene that makes a protein
     that restricts the cell’s ability to divide
  2) An oncogene is one whose protein product
     stimulates growth and cell division. Mutations of
     an oncogene cause it to be permanently active
Proto-oncongenes
MAP Kinase Signal Transduction
Tumor Suppression
• Tumor suppressors inhibit transcription of genes that
  would cause increased replication
• When a mutation occurs in any suppressor,
  replication and division become uncontrolled and
  tumors result
Action of p53
• Mutations in the p53
  gene are found in
  more than 50% of all
  human cancers
How do We Fight Cancer?
• Cancer has been treated in a variety of ways
• Traditional approaches include:
  1) Surgeries to remove tumors
  2) Radiation and chemotherapy
  3) Treatment with monoclonal antibodies to target
  specific tumors
• More current foci include attempts to reactivate p53
  in cancerous tissues when they have lost their
  function
Drug Targets in the p53 Pathway
Transductional Targeting in Virotherapy
Transcriptional Targeting in Virotherapy
(Cont’d)
Summary
• All potentially fatal cancers have several things in
  common, such as having cells that are immortal, that
  divide despite “stop growth” signals from nearby
  cells, that stimulate blood-vessel formation near to
  themselves, and that spread to other parts of the
  body

• The development of cancer requires multiple
  breakdowns in normal metabolism
Summary (Cont’d)
• Most cancers have been linked to specific genes
  called oncogenes or to tumor-suppressor genes.
  When these genes mutated, the cell loses the ability
  to control its replication

• There are many classical ways to fight cancer, such
  as radiation therapy and chemotherapy

• Novel techniques using viruses are now being tried
  to target cancer cells more directly, and some of
  these are showing tremendous promise

Más contenido relacionado

La actualidad más candente

Transplant immunology final ppt
Transplant immunology final pptTransplant immunology final ppt
Transplant immunology final pptDrTasneem Siddiqui
 
HLA and antigen presentation
HLA and antigen presentationHLA and antigen presentation
HLA and antigen presentationPooja Dhaka
 
Transplant immunology edd[1]
Transplant immunology edd[1]Transplant immunology edd[1]
Transplant immunology edd[1]rabbibaidoo
 
Immunology of tanslanatation and malignancy
Immunology of tanslanatation and malignancyImmunology of tanslanatation and malignancy
Immunology of tanslanatation and malignancyraghunathp
 
Transplant immunity & Transplantation_sandhya
Transplant immunity & Transplantation_sandhyaTransplant immunity & Transplantation_sandhya
Transplant immunity & Transplantation_sandhyaSandhya Kulkarni
 
Immunotherapeutics ( types of Immunotherapeutics & humanization antibody ther...
Immunotherapeutics ( types of Immunotherapeutics & humanization antibody ther...Immunotherapeutics ( types of Immunotherapeutics & humanization antibody ther...
Immunotherapeutics ( types of Immunotherapeutics & humanization antibody ther...Rashmi116
 
Mucosal associated
Mucosal associatedMucosal associated
Mucosal associatedSmawi GH
 
T6α EFFECTOR FUNCTIONS AND MEMORY RESPONSE
T6α EFFECTOR FUNCTIONS AND MEMORY RESPONSET6α EFFECTOR FUNCTIONS AND MEMORY RESPONSE
T6α EFFECTOR FUNCTIONS AND MEMORY RESPONSEJeremy Brassard
 
Transplantation and tissue rejection
Transplantation and tissue rejectionTransplantation and tissue rejection
Transplantation and tissue rejectionjagan vana
 

La actualidad más candente (19)

Transplantation
TransplantationTransplantation
Transplantation
 
Transplant immunology final ppt
Transplant immunology final pptTransplant immunology final ppt
Transplant immunology final ppt
 
Cancer and immunology
Cancer and immunologyCancer and immunology
Cancer and immunology
 
HLA and antigen presentation
HLA and antigen presentationHLA and antigen presentation
HLA and antigen presentation
 
5 tumor biotherapy
5 tumor biotherapy5 tumor biotherapy
5 tumor biotherapy
 
Transplant immunology edd[1]
Transplant immunology edd[1]Transplant immunology edd[1]
Transplant immunology edd[1]
 
Immunotherapy of tumor
Immunotherapy of tumorImmunotherapy of tumor
Immunotherapy of tumor
 
Immunology of tanslanatation and malignancy
Immunology of tanslanatation and malignancyImmunology of tanslanatation and malignancy
Immunology of tanslanatation and malignancy
 
A P+ Bio+ H B S+Master
A P+ Bio+ H B S+MasterA P+ Bio+ H B S+Master
A P+ Bio+ H B S+Master
 
Immunology
ImmunologyImmunology
Immunology
 
Transplant immunity & Transplantation_sandhya
Transplant immunity & Transplantation_sandhyaTransplant immunity & Transplantation_sandhya
Transplant immunity & Transplantation_sandhya
 
Immunotherapeutics ( types of Immunotherapeutics & humanization antibody ther...
Immunotherapeutics ( types of Immunotherapeutics & humanization antibody ther...Immunotherapeutics ( types of Immunotherapeutics & humanization antibody ther...
Immunotherapeutics ( types of Immunotherapeutics & humanization antibody ther...
 
Immunotherapy of Cancer I
Immunotherapy of Cancer IImmunotherapy of Cancer I
Immunotherapy of Cancer I
 
Transplantation immunology
Transplantation immunologyTransplantation immunology
Transplantation immunology
 
Mucosal associated
Mucosal associatedMucosal associated
Mucosal associated
 
Transplantation
Transplantation Transplantation
Transplantation
 
Chapter 1 The Basic Immunology
Chapter 1  The Basic ImmunologyChapter 1  The Basic Immunology
Chapter 1 The Basic Immunology
 
T6α EFFECTOR FUNCTIONS AND MEMORY RESPONSE
T6α EFFECTOR FUNCTIONS AND MEMORY RESPONSET6α EFFECTOR FUNCTIONS AND MEMORY RESPONSE
T6α EFFECTOR FUNCTIONS AND MEMORY RESPONSE
 
Transplantation and tissue rejection
Transplantation and tissue rejectionTransplantation and tissue rejection
Transplantation and tissue rejection
 

Destacado

Metabolism i-chp-15-bioc-361-version-oct-2012 - Intro
Metabolism i-chp-15-bioc-361-version-oct-2012 - IntroMetabolism i-chp-15-bioc-361-version-oct-2012 - Intro
Metabolism i-chp-15-bioc-361-version-oct-2012 - IntroJody Haddow
 
Metabolism ii-chp-17-bioc-361-version-dec-2012 - Glycolysis
Metabolism ii-chp-17-bioc-361-version-dec-2012 - GlycolysisMetabolism ii-chp-17-bioc-361-version-dec-2012 - Glycolysis
Metabolism ii-chp-17-bioc-361-version-dec-2012 - GlycolysisJody Haddow
 
Proteins chp-4-bioc-361-version-oct-2012b
Proteins chp-4-bioc-361-version-oct-2012bProteins chp-4-bioc-361-version-oct-2012b
Proteins chp-4-bioc-361-version-oct-2012bJody Haddow
 
1 campbell ch07-haddow-spring2013-130219
1 campbell ch07-haddow-spring2013-1302191 campbell ch07-haddow-spring2013-130219
1 campbell ch07-haddow-spring2013-130219Jody Haddow
 
Enzymes chp-6-7-bioc-361-version-oct-2012b
Enzymes chp-6-7-bioc-361-version-oct-2012bEnzymes chp-6-7-bioc-361-version-oct-2012b
Enzymes chp-6-7-bioc-361-version-oct-2012bJody Haddow
 
Chem symposium-haddow-oct-2012b
Chem symposium-haddow-oct-2012bChem symposium-haddow-oct-2012b
Chem symposium-haddow-oct-2012bJody Haddow
 
Protein purification chp-5-bioc-361-version-oct-2012
Protein purification chp-5-bioc-361-version-oct-2012Protein purification chp-5-bioc-361-version-oct-2012
Protein purification chp-5-bioc-361-version-oct-2012Jody Haddow
 
Carbohydrate metabolism, part 1
Carbohydrate metabolism, part 1Carbohydrate metabolism, part 1
Carbohydrate metabolism, part 1enamifat
 
Glycolysis ppt
Glycolysis pptGlycolysis ppt
Glycolysis pptVBCOPS
 
Carbohydrate Metabolism - Biochemistry
Carbohydrate Metabolism - BiochemistryCarbohydrate Metabolism - Biochemistry
Carbohydrate Metabolism - BiochemistryCU Dentistry 2019
 
Bioquímica-Peter & Campbell
Bioquímica-Peter & CampbellBioquímica-Peter & Campbell
Bioquímica-Peter & CampbellBlack Lotus
 

Destacado (14)

Metabolism i-chp-15-bioc-361-version-oct-2012 - Intro
Metabolism i-chp-15-bioc-361-version-oct-2012 - IntroMetabolism i-chp-15-bioc-361-version-oct-2012 - Intro
Metabolism i-chp-15-bioc-361-version-oct-2012 - Intro
 
Metabolism ii-chp-17-bioc-361-version-dec-2012 - Glycolysis
Metabolism ii-chp-17-bioc-361-version-dec-2012 - GlycolysisMetabolism ii-chp-17-bioc-361-version-dec-2012 - Glycolysis
Metabolism ii-chp-17-bioc-361-version-dec-2012 - Glycolysis
 
Proteins chp-4-bioc-361-version-oct-2012b
Proteins chp-4-bioc-361-version-oct-2012bProteins chp-4-bioc-361-version-oct-2012b
Proteins chp-4-bioc-361-version-oct-2012b
 
1 campbell ch07-haddow-spring2013-130219
1 campbell ch07-haddow-spring2013-1302191 campbell ch07-haddow-spring2013-130219
1 campbell ch07-haddow-spring2013-130219
 
Enzymes chp-6-7-bioc-361-version-oct-2012b
Enzymes chp-6-7-bioc-361-version-oct-2012bEnzymes chp-6-7-bioc-361-version-oct-2012b
Enzymes chp-6-7-bioc-361-version-oct-2012b
 
Chem symposium-haddow-oct-2012b
Chem symposium-haddow-oct-2012bChem symposium-haddow-oct-2012b
Chem symposium-haddow-oct-2012b
 
Class 2 glycolysis
Class 2  glycolysisClass 2  glycolysis
Class 2 glycolysis
 
Protein purification chp-5-bioc-361-version-oct-2012
Protein purification chp-5-bioc-361-version-oct-2012Protein purification chp-5-bioc-361-version-oct-2012
Protein purification chp-5-bioc-361-version-oct-2012
 
Carbohydrate metabolism, part 1
Carbohydrate metabolism, part 1Carbohydrate metabolism, part 1
Carbohydrate metabolism, part 1
 
Glycolysis ppt
Glycolysis pptGlycolysis ppt
Glycolysis ppt
 
Glycolysis
GlycolysisGlycolysis
Glycolysis
 
Carbohydrate Metabolism - Biochemistry
Carbohydrate Metabolism - BiochemistryCarbohydrate Metabolism - Biochemistry
Carbohydrate Metabolism - Biochemistry
 
Carbohydrate metabolism
Carbohydrate metabolismCarbohydrate metabolism
Carbohydrate metabolism
 
Bioquímica-Peter & Campbell
Bioquímica-Peter & CampbellBioquímica-Peter & Campbell
Bioquímica-Peter & Campbell
 

Similar a 5 campbell ch14-haddow-spring2013-130304

L1.0 Immune System component .pptx
L1.0 Immune System component .pptxL1.0 Immune System component .pptx
L1.0 Immune System component .pptxdanielmwandu
 
L1.0 Immune System component .pptx
L1.0 Immune System component .pptxL1.0 Immune System component .pptx
L1.0 Immune System component .pptxAngelCharles7
 
Chapter 17 immune system and diseases
Chapter 17 immune system and diseasesChapter 17 immune system and diseases
Chapter 17 immune system and diseasesTia Hohler
 
Cancer Immunotherapy
Cancer ImmunotherapyCancer Immunotherapy
Cancer ImmunotherapyAsokan R
 
Antigen processing-and-presentation-09
Antigen processing-and-presentation-09Antigen processing-and-presentation-09
Antigen processing-and-presentation-09Dr.Dinesh Jain
 
Hiv life cycle and immune system basics presentation - tacp 4 18 2013
Hiv life cycle and immune system basics  presentation - tacp 4 18 2013Hiv life cycle and immune system basics  presentation - tacp 4 18 2013
Hiv life cycle and immune system basics presentation - tacp 4 18 2013thendersondccare
 
General description of immune system
General description of immune systemGeneral description of immune system
General description of immune systemshahnazbano9
 
Dr. David Hurley - The Chaos of Vaccine Responses: The Importance of Tissue-L...
Dr. David Hurley - The Chaos of Vaccine Responses: The Importance of Tissue-L...Dr. David Hurley - The Chaos of Vaccine Responses: The Importance of Tissue-L...
Dr. David Hurley - The Chaos of Vaccine Responses: The Importance of Tissue-L...John Blue
 
T CELL INTERACTINS WITH PERIODNTAL DISEASES
T CELL INTERACTINS WITH PERIODNTAL DISEASES T CELL INTERACTINS WITH PERIODNTAL DISEASES
T CELL INTERACTINS WITH PERIODNTAL DISEASES Dr. Saurabh Jain
 
Radiation protection: antigen presenting cells.
Radiation protection: antigen presenting cells.Radiation protection: antigen presenting cells.
Radiation protection: antigen presenting cells.Dmitri Popov
 
Cancer and immune system
Cancer and immune systemCancer and immune system
Cancer and immune systemNidaSajjad2
 
Immunosuppression and immune tolerance ppt
Immunosuppression and immune tolerance pptImmunosuppression and immune tolerance ppt
Immunosuppression and immune tolerance pptBharathiar university
 
DLHB2j6YnYTdcGMN13.pptxvvcctfgtggfyggggfyt
DLHB2j6YnYTdcGMN13.pptxvvcctfgtggfyggggfytDLHB2j6YnYTdcGMN13.pptxvvcctfgtggfyggggfyt
DLHB2j6YnYTdcGMN13.pptxvvcctfgtggfyggggfytrohitdushyant8
 
IMMUNODEFICIENCIES lecture for bach.pptx
IMMUNODEFICIENCIES lecture for bach.pptxIMMUNODEFICIENCIES lecture for bach.pptx
IMMUNODEFICIENCIES lecture for bach.pptxssuser504dda
 

Similar a 5 campbell ch14-haddow-spring2013-130304 (20)

L1.0 Immune System component .pptx
L1.0 Immune System component .pptxL1.0 Immune System component .pptx
L1.0 Immune System component .pptx
 
L1.0 Immune System component .pptx
L1.0 Immune System component .pptxL1.0 Immune System component .pptx
L1.0 Immune System component .pptx
 
Chapter 17 immune system and diseases
Chapter 17 immune system and diseasesChapter 17 immune system and diseases
Chapter 17 immune system and diseases
 
Cancer Immunotherapy
Cancer ImmunotherapyCancer Immunotherapy
Cancer Immunotherapy
 
Antigen processing-and-presentation-09
Antigen processing-and-presentation-09Antigen processing-and-presentation-09
Antigen processing-and-presentation-09
 
Hiv life cycle and immune system basics presentation - tacp 4 18 2013
Hiv life cycle and immune system basics  presentation - tacp 4 18 2013Hiv life cycle and immune system basics  presentation - tacp 4 18 2013
Hiv life cycle and immune system basics presentation - tacp 4 18 2013
 
General description of immune system
General description of immune systemGeneral description of immune system
General description of immune system
 
Dr. David Hurley - The Chaos of Vaccine Responses: The Importance of Tissue-L...
Dr. David Hurley - The Chaos of Vaccine Responses: The Importance of Tissue-L...Dr. David Hurley - The Chaos of Vaccine Responses: The Importance of Tissue-L...
Dr. David Hurley - The Chaos of Vaccine Responses: The Importance of Tissue-L...
 
T CELL INTERACTINS WITH PERIODNTAL DISEASES
T CELL INTERACTINS WITH PERIODNTAL DISEASES T CELL INTERACTINS WITH PERIODNTAL DISEASES
T CELL INTERACTINS WITH PERIODNTAL DISEASES
 
Radiation protection: antigen presenting cells.
Radiation protection: antigen presenting cells.Radiation protection: antigen presenting cells.
Radiation protection: antigen presenting cells.
 
Cancer and immune system
Cancer and immune systemCancer and immune system
Cancer and immune system
 
Immunosuppression and immune tolerance ppt
Immunosuppression and immune tolerance pptImmunosuppression and immune tolerance ppt
Immunosuppression and immune tolerance ppt
 
Immunosurveillance
ImmunosurveillanceImmunosurveillance
Immunosurveillance
 
DLHB2j6YnYTdcGMN13.pptxvvcctfgtggfyggggfyt
DLHB2j6YnYTdcGMN13.pptxvvcctfgtggfyggggfytDLHB2j6YnYTdcGMN13.pptxvvcctfgtggfyggggfyt
DLHB2j6YnYTdcGMN13.pptxvvcctfgtggfyggggfyt
 
Ch 43 immunity
Ch 43 immunityCh 43 immunity
Ch 43 immunity
 
Cells of immune
Cells of immuneCells of immune
Cells of immune
 
IMMUNODEFICIENCIES lecture for bach.pptx
IMMUNODEFICIENCIES lecture for bach.pptxIMMUNODEFICIENCIES lecture for bach.pptx
IMMUNODEFICIENCIES lecture for bach.pptx
 
Unit 3.pptx
Unit 3.pptxUnit 3.pptx
Unit 3.pptx
 
Immunology Notes
Immunology NotesImmunology Notes
Immunology Notes
 
Immunology P.O.M.
Immunology P.O.M.Immunology P.O.M.
Immunology P.O.M.
 

5 campbell ch14-haddow-spring2013-130304

  • 1. Mary K. Campbell Shawn O. Farrell http://academic.cengage.com/chemistry/campbell Chapter 14 Viruses, Cancer, and Immunology Paul D. Adams • University of Arkansas
  • 2. Viruses • Viruses are pathogens of bacteria, plants, and animals • Can be deadly (e.g., Ebola, HIV) • Can be merely annoying (e.g., Rhinovirus) • Viruses are small particles composed of nucleic acid and protein • Entire particle is known as a virion • Capsid- surround the center of the virion • Nucleocapsid- combination of the nucleic acid and the capsid • Membrane envelope- surrounds the nucleocapsid • Protein spikes- help viruses attach themselves to the host cell
  • 6. How Does a Virus Infect a Cell • A Virus must attach to the host cell before it can penetrate • A common method of attachment involves the binding of one of the spike proteins on envelope of the virus to a specific receptor on the host cell • An example is HIV attachment
  • 7. Retroviruses • A retrovirus implies that replication is backward compared to the central dogma of molecular biology • The genome of a retrovirus is single-stranded RNA • Once it infects the cell, the RNA strand is used as template to make double-stranded DNA • Retroviruses have been linked to cancer and AIDS
  • 8. Life cycle of a Retrovirus
  • 9. Retroviruses (Cont’d) • Retroviruses have certain genes in common • Coat proteins- genes for proteins of the nucleoplasmid • All retroviruses have genes for reverse transcriptase (RT), and for envelope proteins (EP)
  • 11. - TMV, a virus of tobacco plants, is a filamentous RNA virus. Top right: some of the capsid proteins (cyan) have been stripped away to reveal the RNA helix (yellow). - The capsid normally consists of 2130 coat protein molecules (with 16.3 units per turn of the helix) and is about 300 nm long by 18 nm in diameter - The genome is ss(+)RNA, that is a single-strand of positive-sense RNA,
  • 12. HIV Genome http://www.hiv.lanl.gov/content/sequence/HIV/MAP/landmark.html The HIV-1 genome contains a single promoter and uses multiple reading frames and alternative splicing to encode 15 proteins from a single pre- mRNA species.
  • 13. Summary of Retroviruses • Retroviruses have a genome based on DNA. When they infect cells, their RNA is turned into DNA by RT. The DNA is then incorporated into the host’s DNA genome as a part of the replication cycle for the virus • Retroviruses all have certain genes in common • Some retroviruses also have identifiably unique genes, e.g., the Sarcoma oncogene and the Rous sarcoma virus - Viruses are also used in Gene Therapy (see Biochemical Connections, pg. 412)
  • 14. US HIV baby 'cured' by early drug treatment News headline - Mar 4 2013 • A baby girl in the US born with HIV appears to have been cured after very early treatment with standard drug therapy, doctors say. • The Mississippi child is now two-and-a-half years old and has been off medication for about a year with no signs of infection. • More testing needs to be done to see if the treatment - given within hours of birth - would work for others. • If the girl stays healthy, it would be the world's second reported 'cure'. • Dr Deborah Persaud, a virologist at Johns Hopkins University in Baltimore, presented the findings at the Conference on Retroviruses and Opportunistic Infections in Atlanta. • "This is a proof of concept that HIV can be potentially curable in infants," she said. • Cocktail of drugs In 2007, Timothy Ray Brown became the first person in the world believed to have recovered from HIV. • His infection was eradicated through an elaborate treatment for leukaemia that involved the destruction of his immune system and a stem cell transplant from a donor with a rare genetic mutation that resists HIV infection. • In contrast, the case of the Mississippi baby involved a cocktail of widely available drugs, known as antiretroviral therapy, already used to treat HIV infection in infants. • It suggests the swift treatment wiped out HIV before it could form hideouts in the body. • These so-called reservoirs of dormant cells usually rapidly reinfect anyone who stops medication, said Dr Persaud.
  • 15. Death toll from new SARS-like virus climbs to NINE – March 12 2013 • http://edition.cnn.com/2013/03/13/health/new-coronavirus-case/index.html?eref=mrss_igoogle_cnn • March 13 2013, (CNN) -- There has been another confirmed case of a mysterious new SARS-like virus. • The Saudi health ministry informed the World Health Organization that a 39-year-old man was hospitalized with the novel coronavirus on February 28 and died two days later. • So far, WHO has recorded 15 confirmed cases of the novel coronavirus, including nine deaths, since the fall. • The spread of coronavirus in UK • The Saudi patient did not appear to have had any contact with anyone who was already infected. As a result, WHO is investigating other potential exposure sources.
  • 16. Viruses – Biochemical connections • Read Gene Therapy Page 412-413 • Adenosine deaminase • Severe combined immune deficiency (SCID)
  • 18. The Immune System • The immune system allows for the distinction between self from nonself • This allows cells and molecules responsible for immunity to recognize and destroy pathogens • The immune system can also go awry in distinguishing self from nonself. This results in an autoimmune disease, in which the immune system attacks the body’s own tissues • Allergies are also another type of improper functioning of the immune system • Can be cellular, molecular, acquired or innate (always present)
  • 19. Innate Immunity • There are several parts to innate immunity: physical barriers(skin, mucus), cells of the immune system (dendritic cells, macrophage, and natural killer (NK) cells) • Dendritic cells are members of a class of cells called antigen-presenting cells (APCs) (1st line of defense) • T cells release chemicals called cytokines that stimulate other members of the immune system, e.g. killer T cells and B cells (a level of control) • Another important cell type in the innate immunity system is the natural killer (NK) cells, which is a type of leukocyte.
  • 22. Innate Immunity (T-cells) • T cells or T lymphocytes belong to a group of white blood cells known as lymphocytes, • play a central role in cell-mediated immunity. • They can be distinguished from other lymphocytes, such as B cells and natural killer cells (NK cells), by the presence of a T-cell receptor (TCR) on the cell surface. • TCR binds ANTIGEN • They are called T cells because they mature in the thymus.
  • 23. T Cells cont • There are several subsets of T cells, each with a distinct function. • T cells differentiate, and become specialized for one of several possible functions • Proliferation of killer T cells is triggered when macrophages bound to T cells produce small proteins called interleukins
  • 24. Types of T Cells Helper •(TH cells) assist other white blood cells in immunologic processes, including maturation of B cells into plasma cells and memory B cells, and activation of cytotoxic T cells and macrophages. •become activated when they are presented with peptide antigens by MHC class II molecules, which are expressed on the surface of antigen presenting cells (APCs). •Once activated, they divide rapidly and secrete small proteins called cytokines that regulate or assist in the active immune response. Cytotoxic – Killer (CD8 cell) •(TC cells,) destroy virally infected cells and tumor cells, and are also implicated in transplant rejection. •These cells recognize their targets by binding to antigen associated with MHC class I, which is present on the surface of all nucleated cells.
  • 27. Interaction Between Cytotoxic T cells and Antigen-Presenting Cells Killer T also called a CD8 cells as it is such a distinguishing feature antigen TCR
  • 28. Clonal Selection • The process by which only the cells that respond to a given antigen grow in preference to other T cells is called clonal selection • Double recognition needed = control, activating the immune system is a serious game so you have to be sure!
  • 29. Interaction Between Helper T Cells and Antigen-Presenting Cells
  • 30. How Helper T Cells Aid in the Development of B Cells
  • 31. Antibodies • Antibodies are Y-shaped molecules consisting of two identical heavy chains and two identical light chains held together by disulfide bonds • Antibodies are glycoproteins
  • 32. Antibodies (Cont’d) • The variable region is found at the prongs of the Y and is the part of the antibody that binds to the antigen • The binding sites for the antibody on the antigen are called epitopes
  • 33. Antibody Heavy and Light Chains
  • 35. Antibodies (Cont’d) • If a cell’s receptors encountered self-antigens that are recognized with high affinity, it undergoes a process called negative selection and is programmed for apoptosis, or cell death • There are several safeguards that leads to the delicate balance that must be maintained by the immune system
  • 36. Differentiation of T Cells This section is a huge topic (as all of these sections in this chapter.) However this Selection process is covered very poorly so we wont emphasize it.
  • 37. Summary • Vertebrates have an immune system • Innate immunity consists of physical barriers and cellular warriors • Acquired immunity is based on two types of T cells and on B cells. These cells are generated randomly with receptors that can be specific for an unimaginable number of antigens • When cells encounter their specific antigens, they are stimulated to multiply
  • 38. Summary (cont’d) • When cells encounter their specific antigens, they are stimulated to multiply • Acquired immune cells also leave behind memory cells so that if the same pathogen is seen again, the body is faster to eliminate it • Immune cells must be able to recognize self from nonself. T cells and B cells are conditioned not to recognize proteins from that individual • In some cases, the immune system breaks down, and a person may be attacked by his or her own immune system leading to an autoimmune disease
  • 39. Cancer • Cancer is the leading cause of death in human beings • It is characterized by cells that grow and divide out of control, often spreading to other tissues and causing them to become cancerous
  • 40. Cancer (Cont’d) • All life-threatening cancers have at least six characteristics in common 1) Cancer cells continue to grow and divide in situations in which normal cells do not 2) Cancer cells continue to grow even when the neighboring cells send out “stop-growth” signals 3) Cancer cell manage to keep going and avoid a “self-destruct” signal that usually occurs when DNA damage has occurred 4) The can co-opt the body’s vascular system, causing the growth of new blood vessels to supply the cancerous cells with nutrients 5) They are essentially immortal (cell culture in the lab) 6) Cancer cells have the ability to break loose, travel to other parts of the body and create new which tumors make them lethal, this is called metastasis
  • 41. What Causes Cancer? • Changes in DNA cause changes to specific proteins that are responsible for controlling the cell cycle • Most mutations of DNA affect two types of genes: 1) Tumor suppressor, a gene that makes a protein that restricts the cell’s ability to divide 2) An oncogene is one whose protein product stimulates growth and cell division. Mutations of an oncogene cause it to be permanently active
  • 43. MAP Kinase Signal Transduction
  • 44. Tumor Suppression • Tumor suppressors inhibit transcription of genes that would cause increased replication • When a mutation occurs in any suppressor, replication and division become uncontrolled and tumors result
  • 45. Action of p53 • Mutations in the p53 gene are found in more than 50% of all human cancers
  • 46. How do We Fight Cancer? • Cancer has been treated in a variety of ways • Traditional approaches include: 1) Surgeries to remove tumors 2) Radiation and chemotherapy 3) Treatment with monoclonal antibodies to target specific tumors • More current foci include attempts to reactivate p53 in cancerous tissues when they have lost their function
  • 47. Drug Targets in the p53 Pathway
  • 49. Transcriptional Targeting in Virotherapy (Cont’d)
  • 50. Summary • All potentially fatal cancers have several things in common, such as having cells that are immortal, that divide despite “stop growth” signals from nearby cells, that stimulate blood-vessel formation near to themselves, and that spread to other parts of the body • The development of cancer requires multiple breakdowns in normal metabolism
  • 51. Summary (Cont’d) • Most cancers have been linked to specific genes called oncogenes or to tumor-suppressor genes. When these genes mutated, the cell loses the ability to control its replication • There are many classical ways to fight cancer, such as radiation therapy and chemotherapy • Novel techniques using viruses are now being tried to target cancer cells more directly, and some of these are showing tremendous promise